Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 67 for “"Fingolimod"”.
-
Untersuchung der natürlichen Killerzellen (NK-Zellen) unter Fingolimod-Behandlung
Fingolimod (FTY720, Gilenya®), ein funktioneller Sphingosin-1-Phosphat-Rezeptor (S1PR) Antagonist, ist seit 2011 in der Europäischen Union ein zugelassenes Medikament zur Behandlung der Multiple Sklerose (MS). Es bewirkt das Zurückhalten von S1PR1-exprimierenden Immunzellen im Lymphknoten (LK). …
-
Preclinical characterisation of fingolimod as a potential therapeutic agent for stroke
… in preclinical and clinical stroke studies is fingolimod, an FDA approved drug for the treatment of multiple sclerosis. Even though there are several studies supporting the effectiveness of fingolimod for the treatment of stroke, the recommended characterisation based on the Stroke Treatment …
-
Stabilized Fingolimod Nanoemulsion Ophthalmic Formulation for the Treatment of Retinal Degeneration
Fingolimod (FTY) is a sphingosine-1-phosphate receptor agonist and an inhibitor of ceramide synthase, reducing cellular ceramide levels and mitigating photoreceptor degeneration. The current research focuses on enhancing the stability of a previously reported FTY nanoemulsion (FTY-NE) topical …
-
Fingolimod and skin cancer risk among people with multiple sclerosis : pharmacoepidemiologic and causal inference studies
The full abstract for this thesis is available in the body of the thesis, and will be available when the embargo expires.
-
Partitioning and diffusion studies of bodipy-fingolimod analogs, immune suppressors, in mouse embryonic fibroblast cells
Sphingosine-1-phosphate is a bioactive signaling molecule that mediates important cellular functions such as cell proliferation, cytoskeletal rearrangement, angiogenesis, mobilization of intracellular calcium and immune cell trafficking. FTY720, a synthetic analog of sphingosine that has …
-
Disease Modifying Agents Use and Associated Outcomes in Multiple Sclerosis
… the factors associated with selection of oral fingolimod versus injectable DMA; (ii) compare the adherence trajectories between oral fingolimod and injectable DMA users; and (iii) assess the comparative effectiveness (relapse /DMA treatment switch) between oral fingolimod and injectable DMA …
-
Der Effekt von Fingolimod auf die B-Zell-Distribution und -Aggregation in einem chronischen Mausmodell der Multiplen Sklerose
… den Effekt des S1P1-Rezeptor-Modulators FTY720 (Fingolimod) auf die Immunantwort der autoreaktiven B-Zellen in der Peripherie sowie im ZNS. Methoden - MP4-immunisierte Mäuse erhielten 50 Tage nach dem EAE-Krankheitsbeginn oral appliziertes FTY720 über einen Zeitraum von 30 Tagen. Die Tiere wurden …
-
Impact of fingolimod treatment on motor neuron survival and neuroinflammation in the spinal cord of a mouse model of ALS
… the action of glial cells throughout the CNS. Fingolimod is a sphingosine analog that is used as a treatment for multiple sclerosis (MS), mainly through activating sphingosine-1-phosphate receptor 1 (S1PR1), and 1) prevents release of peripheral lymphocytes from the lymph nodes that become …
-
Der Einfluss von Fingolimod auf die autoreaktive B-Zell-Antwort in einem B-Zell-abhängigen Mausmodell der Multiplen Sklerose
… des Sphingosin-1-Phosphat-Rezeptor-Modulators Fingolimod (FTY720) auf die autoreaktive B-Zell-Antwort und speziell die Bildung von B-Zell-Aggregaten im Kleinhirn der MP4-EAE-Mäuse untersucht.
-
Deconvolution of small molecule pleiotropic effects during immunomodulation
… This research has identified a small molecule, fingolimod, which induces lymphangiogenesis while also demonstrating previously reported pleiotropic effects upon both the lymphatic and immune system (i.e. T-lymphocyte sequestration in lymph nodes and T-lymphocyte migration inhibition).</p> <p>The …
-
The role of regulatory T cells in stroke recovery
… Treg-targeted stroke immunotherapies, namely fingolimod and recombinant pregnancy-specific glycoprotein-1 (rPSG1-Fc). Methods: The effect of fingolimod on Tregs in a mouse model of permanent brain ischaemia was first investigated using a combination of flow cytometry and immunohistochemistry. …
-
Sphingosine-1-Phosphate and Fingolimod (FTY720) Regulate ICl,swell In HL-1 Cardiac Myocytes via Intracellular Binding And Mitochondrial ROS Production
… signaling. S1P and its analog, FTY720 (fingolimod), primarily act via G-protein coupled receptors (S1PR; S1PR1-3 in heart), but several intracellular S1P ligands are known. We investigated how these agents regulate ICl,swell. ICl,swell was elicited by bath S1P (500 nM), FTY720 (S1PR1,3 …
-
Modulação de ZEB1 em células de meduloblastoma humano
… relacionado à malignidade em diversos tumores. O fingolimod está emergindo como terapia antitumoral por inibir histonas deacetilases, modular a expressão gênica e interferir em processos essenciais à sobrevivência do câncer. O objetivo deste trabalho foi investigar a expressão de ZEB1 em …
-
PRG4/CD44/PP2A Signaling Axis: A Significant Regulator of Gout Arthritis
… TLR2 agonist and stimulated with MSU crystals. Fingolimod (PP2A activating drug) and febuxostat (XO inhibitor) were assessed for their ability to regulate PP2A and XO activity, UA production, ROS generation and IL-1b secretion. Anti-inflammatory effect of fingolimod was assessed in vivo. …
-
Sphingosine kinase-1 regulates neutrophil recruitment during allergic inflammation
… molecule sphingosine-1-phosphate (S1P). Fingolimod (Gilenya) is an FDA approved oral drug currently used to treat multiple sclerosis via its effects on SK and S1P axis. Herein, I reveal that Fingolimod can inhibit histamine-induced neutrophil recruitment in vitro and in vivo. In addition, …
Page 1 of 4